Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zea Biosciences is a biotechnology company specializing in plant-based biologics manufacturing through its proprietary Zea Lighthouse platform. The company utilizes molecular farming to produce high-quality, scalable, and cost-effective recombinant proteins, vaccines, and monoclonal antibodies within a controlled indoor environment. By leveraging hydroponic systems and optimized growth conditions, Zea aims to overcome the limitations of traditional bioreactor-based production. Their technology supports rapid scale-up and provides a sustainable alternative for the pharmaceutical and nutraceutical industries. The platform is designed to ensure consistency and purity in the production of complex biologics, catering to both research and commercial needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zea.